Revisiting Fat Graft Harvesting and Processing Technique to Optimize Its Regenerative Potential.
Karina K., Biben JA., Ekaputri K., Krisandi G., Rosadi I., Sobariah S.
Prospective Study with a reported sample of 21, published in Plast Reconstr Surg Glob Open (2025) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- Plast Reconstr Surg Glob Open (2025)
- Country
- United States
- Reported sample size
- 21
- Source database
- PubMed
- PMID
- 39802276
- PMCID
- PMC11723667
- DOI
- 10.1097/GOX.0000000000006420
- Citations
- 2
Abstract (original English)
Background The use of fat grafting has expanded to include cell and tissue regeneration, necessitating investigations to ensure the viability of stromal and adipose-derived mesenchymal stem cells (ASCs) within the transferred fat parcels. This study explored the impact of harvesting technique and centrifugation on the viability of stromal cells and ASCs in lipoaspirate. Methods Fat was harvested from patients undergoing fat grafting using 2 types of liposuction cannula: (A) a 3-mm blunt tip cannula with 3 smooth holes and (B) a 2.4-mm, sharp point port, multihole blunt tip cannula. Fat from cannula B underwent different processing methods: no centrifugation, 300 g , 600 g , and 900 g centrifugation. Stromal cells were isolated, quantified, and evaluated for viability. ASCs were cultured from these samples to confirm survival. Results Lipoaspirates from 21 patients were analyzed. The mean stromal cell counts were 0.937 × 10 9 ± 0.346 × 10 9 /mL for cannula A and 0.734 × 10 9 ± 0.266 × 10 9 /mL for cannula B ( P = 0.684), with viabilities of 98.79% and 98.22% ( P = 0.631), respectively. ASCs isolated and after 2-passage culture were also higher for cannula A. Stromal cell quantification and viability were lowest in the noncentrifuged group ( P g centrifugation group. Conclusions Fat harvesting using cannulas A and B showed no significant difference in stromal cell yield or viabil
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.